Back to CVE records
High 8.8Known exploited (CISA KEV)Published Nov 25, 2019

CVE-2019-13720Use after free in WebAudio in Google Chrome prior to 78.0.3904.87 allowed a remote attacker to potentially exploit heap corruption via a crafted HTML page.

Updated under an hour ago ()

Does this affect you?

It affects Google Chrome and 1 other product. Add what you run to find out whether that includes you.

CISA lists it as known exploited since May 23, 2022; federal agencies had to remediate by Jun 13, 2022. Treat that date as your deadline.

Use after free in WebAudio in Google Chrome prior to 78.0.3904.87 allowed a remote attacker to potentially exploit heap corruption via a crafted HTML page.

CVSS
8.8 HIGH (v3.1, CISA ADP)CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H
Weakness (CWE)
CWE-416
Known exploited
Added to CISA KEV May 23, 2022; federal remediation due Jun 13, 2022Apply updates per vendor instructions.
EPSS (exploitation in the next 30 days)
49.42% (percentile 99)
Assigned by
Chrome
NVD analysis
Analyzed
Record last updated
Oct 21, 2025
First seen by InfoSec Signals
Oct 9, 2026

Affected products

Affected products
Google Chrome
google:chrome (from the name)
from unspecified before 78.0.3904.87
CNA record
google chrome
google:chrome
before 78.0.3904.87
NVD
opensuse leap
opensuse:leap
15.1
NVD

References

  • x-refsource-misc, permissions-required
  • x-refsource-misc, vendor-advisory
  • vendor-advisory, x-refsource-suse, mailing-list, third-party-advisory
  • vendor-advisory, x-refsource-gentoo, third-party-advisory
  • x-refsource-misc, exploit, third-party-advisory, vdb-entry
  • us-government-resource

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.